MAST: a hybrid Multi-Agent Spatio-Temporal model of tumor microenvironment informed using a data-driven approach.
Journal
Bioinformatics advances
ISSN: 2635-0041
Titre abrégé: Bioinform Adv
Pays: England
ID NLM: 9918282081306676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
11
2022
accepted:
03
12
2022
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
27
1
2023
Statut:
epublish
Résumé
Recently, several computational modeling approaches, such as agent-based models, have been applied to study the interaction dynamics between immune and tumor cells in human cancer. However, each tumor is characterized by a specific and unique tumor microenvironment, emphasizing the need for specialized and personalized studies of each cancer scenario. We present MAST, a hybrid Multi-Agent Spatio-Temporal model which can be informed using a data-driven approach to simulate unique tumor subtypes and tumor-immune dynamics starting from high-throughput sequencing data. It captures essential components of the tumor microenvironment by coupling a discrete agent-based model with a continuous partial differential equations-based model.The application to real data of human colorectal cancer tissue investigating the spatio-temporal evolution and emergent properties of four simulated human colorectal cancer subtypes, along with their agreement with current biological knowledge of tumors and clinical outcome endpoints in a patient cohort, endorse the validity of our approach. MAST, implemented in Python language, is freely available with an open-source license through GitLab (https://gitlab.com/sysbiobig/mast), and a Docker image is provided to ease its deployment. The submitted software version and test data are available in Zenodo at https://dx.doi.org/10.5281/zenodo.7267745. Supplementary data are available at
Identifiants
pubmed: 36699399
doi: 10.1093/bioadv/vbac092
pii: vbac092
pmc: PMC9744439
doi:
Types de publication
Journal Article
Langues
eng
Pagination
vbac092Informations de copyright
© The Author(s) 2022. Published by Oxford University Press.
Références
Mol Cancer. 2019 Mar 30;18(1):67
pubmed: 30927930
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Biophys Rev. 2021 Feb 11;13(2):185-202
pubmed: 34290841
Cancers (Basel). 2021 Mar 19;13(6):
pubmed: 33808627
Nat Rev Cancer. 2020 Jun;20(6):343-354
pubmed: 32341552
Genes (Basel). 2018 Nov 28;9(12):
pubmed: 30487452
Clin Cancer Res. 2015 Nov 15;21(22):5047-56
pubmed: 26567364
Clin Cancer Res. 2016 Dec 1;22(23):5642-5650
pubmed: 27698000
J Autoimmun. 2019 Nov;104:102333
pubmed: 31564474
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10985-90
pubmed: 16832064
Elife. 2017 Nov 13;6:
pubmed: 29130882
Bioinformatics. 2019 Jul 15;35(14):i436-i445
pubmed: 31510660
Cancer Res. 2017 Nov 15;77(22):6442-6452
pubmed: 28923860
J R Soc Interface. 2017 Sep;14(134):
pubmed: 28931635
Bioinformatics. 2022 Jan 19;:
pubmed: 35043939
J Pharmacokinet Pharmacodyn. 2014 Oct;41(5):389-99
pubmed: 25238901
Genome Med. 2019 May 24;11(1):34
pubmed: 31126321
PLoS One. 2018 Mar 2;13(3):e0193498
pubmed: 29499048
Sci Rep. 2016 Sep 23;6:33322
pubmed: 27659691
J Biomed Opt. 2017 Sep 1;22(9):91506
pubmed: 28241323
Cell Death Dis. 2020 Nov 26;11(11):1013
pubmed: 33243969
Bioinformatics. 2009 Sep 15;25(18):2389-96
pubmed: 19578172
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Nat Genet. 2020 Jun;52(6):594-603
pubmed: 32451460
Proc Natl Acad Sci U S A. 2002 May 14;99 Suppl 3:7280-7
pubmed: 12011407
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Nature. 2009 Apr 9;458(7239):719-24
pubmed: 19360079
Crit Rev Biochem Mol Biol. 2019 Jun;54(3):193-207
pubmed: 31162937
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Cancer Res. 2016 Oct 15;76(20):5921-5925
pubmed: 27694601
Front Pharmacol. 2019 Feb 28;10:139
pubmed: 30873025
Int Immunopharmacol. 2020 Sep;86:106700
pubmed: 32590316
J Theor Biol. 2018 Sep 7;452:56-68
pubmed: 29750999
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Semin Cancer Biol. 2018 Oct;52(Pt 2):189-197
pubmed: 29501787
J Exp Med. 2000 Feb 7;191(3):423-34
pubmed: 10662788
Front Immunol. 2019 Apr 30;10:924
pubmed: 31134058
Eur J Cancer. 2016 Nov;68:134-147
pubmed: 27755997
Front Aging. 2022 Jan 03;2:800380
pubmed: 35822012
Clin Cancer Res. 2015 Feb 15;21(4):687-92
pubmed: 25501578
J Clin Invest. 2008 Apr;118(4):1390-7
pubmed: 18357341
Math Med Biol. 2017 Jun 1;34(2):215-240
pubmed: 27094601
Processes (Basel). 2019 Jan;7(1):
pubmed: 30701168